Klotho Neurosciences

(NASDAQ) KLTO

Current Price$0.29

Market Cap$35.16M

Since IPO (2022)-97%

5 YearN/A

1 Year-81%

1 Month-14%

Klotho Neurosciences Financials at a Glance

Market Cap

$35.16M

Revenue (TTM)

$0.00

Net Income (TTM)

-$11.29M

EPS (TTM)

-$0.34

P/E Ratio

-0.86

Dividend

$0.00

Beta (Volatility)

0.51 (Low)

Dividend

$0.00

Beta (Volatility)

0.51 (Low)

Price

$0.29

Volume

5,134,782.388

Open

$0.33

Price

$0.29

Volume

5,134,782.388

Open

$0.33

Previous Close

$0.29

Daily Range

$0.29 - $0.34

52-Week Range

$0.21 - $1.67

Estimated Earnings Date

Mar 30, 2026

Dividend

$0.00

Beta (Volatility)

0.51 (Low)

Price

$0.29

Volume

5,134,782.388

Open

$0.33

Previous Close

$0.29

Daily Range

$0.29 - $0.34

52-Week Range

$0.21 - $1.67

Estimated Earnings Date

Mar 30, 2026

KLTO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Klotho Neurosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Joseph Sinkule, PharmD

Website

www.klothoneuro.com

Headquarters

Omaha, NE 68144, US

KLTO Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-85%

Return on Capital

-75%

Return on Assets

-1%

Earnings Yield

-1.16%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$35.16M

Shares Outstanding

121.24M

Volume

5.13M

Avg. Volume

3.31M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$5.54M

EBITDA

-$5.79M

Operating Cash Flow

-$2.95M

Capital Expenditure

-$123.50K

Free Cash Flow

-$3.07M

Cash & ST Invst.

$63.74K

Total Debt

$271.75K

Klotho Neurosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$35.16M

N/A

Market Cap/Employee

$11.72M

N/A

Employees

N/A

Net Income

-$2.90M

+2.2%

EBITDA

-$1.72M

+41.1%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Total Cash

$7.35M

+14337.6%

Total Debt

$0.00

-100.0%

Accounts Receivable

$339.25K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.10%

N/A

Return on Invested Capital

-75.09%

N/A

Free Cash Flow

-$1.09M

-1.4%

Operating Cash Flow

-$1.09M

-1.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NERVMinerva Neurosciences, Inc.

NERVMinerva Neurosciences, Inc.$4.47+6.68%

IBIOiBio, Inc.

IBIOiBio, Inc.$1.69+5.63%

NRSNNeuroSense Therapeutics Ltd.

NRSNNeuroSense Therapeutics Ltd.$0.80+14.13%

XCURExicure, Inc.

XCURExicure, Inc.$2.31+7.44%

TAOXTAO Synergies Inc.

TAOXTAO Synergies Inc.$3.67-4.43%

CVKDCadrenal Therapeutics, Inc. Common Stock

CVKDCadrenal Therapeutics, Inc. Common Stock$3.50+12.90%

SONNSonnet BioTherapeutics Holdings, Inc.

SONNSonnet BioTherapeutics Holdings, Inc.$1.26-59.35%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CTSHCognizant Technology Solutions

CTSHCognizant Technology Solutions$43.70-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$82.87+0.07%

BFLYButterfly Network

BFLYButterfly Network$8.90+0.56%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.75-0.07%

TAT&T

TAT&T$22.02-0.02%

MSFTMicrosoft

MSFTMicrosoft$379.62+0.00%

Questions About KLTO

What is the current price of Klotho Neurosciences?

Klotho Neurosciences is trading at $0.29 per share.

What is the 52-week range for Klotho Neurosciences?

Over the past 52 weeks, Klotho Neurosciences has traded between $0.21 and $1.67.

How much debt does Klotho Neurosciences have?

As of the most recent reporting period, Klotho Neurosciences reported total debt of $294.54K.

How much cash does Klotho Neurosciences have on hand?

Klotho Neurosciences reported $10.00M in cash and cash equivalents in its most recent financial results.

What is Klotho Neurosciences’s dividend yield?

Klotho Neurosciences does not currently have a dividend yield.

Klotho Neurosciences

Klotho Neurosciences Financials at a Glance

KLTO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Klotho Neurosciences

KLTO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Klotho Neurosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KLTO

What is the current price of Klotho Neurosciences?

What is the 52-week range for Klotho Neurosciences?

How much debt does Klotho Neurosciences have?

How much cash does Klotho Neurosciences have on hand?

What is Klotho Neurosciences’s dividend yield?

Premium Investing Services